logo

For the Inventor, By the Inventor

Richmond, CA, United States of America

Sangamo Biosciences, Inc.


USPTO Granted Patents = 160

% Expired Patents = 25.6



Trademarks = 2

Forward Citations = 8,554

Loading Chart...
Loading Chart...

97 inventors (with patents filed for the assignee):

goldMedal Fyodor Urnov (47 out of 80 patents)

silverMedal Edward J Rebar (43 out of 91 patents)

bronzeMedal Philip D Gregory (38 out of 62 patents)

4.  Jeffrey C Miller (37 out of 88 patents)

5.  Michael C Holmes (34 out of 64 patents)

6.  Casey Christopher Case (26 out of 40 patents)

7.  Andrew Jamieson (24 out of 26 patents)

8.  Stephen P Eisenberg (20 out of 30 patents)

9.  Lei Zhang (20 out of 44 patents)

10.  David Paschon (19 out of 51 patents)

11.  Trevor Collingwood (16 out of 20 patents)

12.  Alan P Wolffe (15 out of 16 patents)

13.  Eric E Jarvis (14 out of 28 patents)

14.  Qiang Liu (13 out of 32 patents)

15.  George N Cox (13 out of 58 patents)


Core Competencies:
Zinc Finger Proteins
Gene Correction
Targeted Integration
Nuclease Activity
Transgene Expression
Stem Cell Modulation
Genomic Modification
Huntington's Disease
Hemophilia B
CRISPR Alternatives
DNA-Binding Proteins
Genetic Disorders

160 patents:

1. 11884930 - Method of inactivating a glucocorticoid receptor gene in an isolated cell (2024-01-30),
2. 9650648 - Methods and compositions for treatment of a genetic condition (2017-05-16),
3. 9631201 - Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis (2017-04-25),
4. 9631187 - Methods and compositions for gene correction (2017-04-25),
5. 9631186 - Methods and compositions for targeted single-stranded cleavage and targeted integration (2017-04-25),
6. 9629930 - Methods and compositions for treating hemophilia B (2017-04-25),
7. 9624509 - Modulation of stem cells using zinc finger proteins (2017-04-18),
8. 9624498 - Methods and compositions for regulation of zinc finger protein expression (2017-04-18),
9. 9616090 - Gene correction of SCID-related genes in hematopoietic stem and progenitor cells (2017-04-11),
10. 9597357 - T cell modifying compounds and uses thereof (2017-03-21),
11. 9574211 - Methods and compositions for prevention or treatment of a disease (2017-02-21),
12. 9567609 - Compositions for linking DNA-binding domains and cleavage domains (2017-02-14),
13. 9567573 - [object Object] (2017-02-14),
14. 9566352 - Methods and compositions for inhibiting viral entry into cells (2017-02-14),
15. 9523098 - Targeted modification of malate dehydrogenase (2016-12-20),
Company Overview
Sangamo Biosciences, Inc. is a biotechnology company based in Richmond, California, specializing in gene editing technologies. The company focuses on the development of innovative therapies utilizing zinc finger proteins for gene correction and targeted integration. Their research encompasses various applications, including genomic modification and stem cell modulation, with a particular emphasis on addressing genetic disorders such as Huntington's disease. Sangamo aims to advance the field of gene therapy through its cutting-edge scientific approaches.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Sangamo Biosciences, Inc. USPTO Patent Assignee Logo
160 Patents

#1 in Richmond, CA

#540 in California

#2,481 in US

#5,157 in the World

Richmond, CA (US)
Richmond, CA, United States of America

Sangamo Biosciences, Inc.

Forward Citations = 8,554

97 inventors:

goldMedal Fyodor Urnov (47 out of 80 patents)

silverMedal Edward J Rebar (43 out of 91 patents)

bronzeMedal Philip D Gregory (38 out of 62 patents)

4.  Jeffrey C Miller (37 out of 88 patents)

5.  Michael C Holmes (34 out of 64 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sangamo Biosciences, Inc.. Retrieved from https://idiyas.com/company/sangamo-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…